Funding Cancellation of MRNK Vaccines in the USA

• Cancellation of 22 MRNK vaccine projects in the USA for $500 million.
• Scientists refute claims about the ineffectiveness of MRNK vaccines.
• MRNK technology allows for rapid responses to outbreaks of infections.

The cancellation of funding for MRNK vaccine research in the USA has caused concern among scientists. On September 6, 2025, Health Minister Robert F. Kennedy commented on the cancellation of 22 projects that received $500 million in funding, including research on vaccines against COVID-19 and influenza.

Kennedy, known for his views on vaccines, asserts that MRNK vaccines do not provide sufficient protection against respiratory infections and plans to redirect funding to "safer" vaccine platforms. However, many experts dispute these claims, emphasizing that MRNK vaccines have saved millions of lives during the pandemic.

Scientists, including Professor Andrew Pollard, argue that MRNK technology has advantages in the speed of vaccine production. They can quickly respond to outbreaks of infections, which is critically important in cases similar to the avian flu H5N1, which is already spreading among birds and large livestock.

Moreover, Kennedy seeks to affirm the advantages of other types of vaccines but overlooks the fact that MRNK technology has already demonstrated its effectiveness and safety. They allow for the rapid development of new vaccines faster than traditional methods, which is crucial for combating new pandemics.

According to experts, the refusal to fund MRNK vaccine research could pose a threat not only to the USA but also to global health security in the field of public health.

Tags: USA/Politics/Well-being/Research